Wynne Callon1, Mary Catherine Beach2, Somnath Saha3,4, Geetanjali Chander2, Ira B Wilson5, Michael Barton Laws5, Victoria Sharp6, Jonathan Cohn7, Richard Moore2, P Todd Korthuis4. 1. Johns Hopkins University School of Medicine, 2024 East Monument Street, Baltimore, MD, 21205, USA. wcallon1@jhmi.edu. 2. Johns Hopkins University School of Medicine, 2024 East Monument Street, Baltimore, MD, 21205, USA. 3. Portland VA Medical Center, Portland, OR, USA. 4. Department of Medicine, Oregon Health Sciences University, Portland, OR, USA. 5. Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, RI, USA. 6. Saint-Lukes Roosevelt, New York, NY, USA. 7. Department of Medicine, Wayne State University, Detroit, MI, USA.
Abstract
BACKGROUND: Substance use is associated with higher rates of antiretroviral non-adherence and poor HIV outcomes. This study examined how HIV care providers assess substance use, and which questions elicit accurate patient disclosures. METHODS: We conducted a conversation analysis of audio-recorded encounters between 56 providers and 162 patients living with HIV (PLWH) reporting active substance use in post-encounter interviews (cocaine or heroin use in the past 30 days, > 4 days intoxicated in past 30 days, or AUDIT score ≥ 8). We assessed the frequency of substance use discussion, characterized the types of questions used by providers, and determined the frequency of accurate patient disclosure by question type. RESULTS: In 55 reports of active substance use, providers already knew about the use (n = 16) or patients disclosed unpromptednn = 39). Among the remaining 155 instances of substance use in which providers had the opportunity to elicit disclosure, 78 reports (50 %) of substance use were not discussed. Of the remaining 77 reports in which the provider asked about substance use, 55 (71 %) patients disclosed and 22 (29 %) did not disclose. Questions were classified as: open-ended (n = 18, "How's the drinking going?"); normalizing (n = 14, "When was the last time you used?"); closed-ended (n = 36, "Have you used any cocaine?"); leading towards non-use (n = 9, "Have you been clean?"). Accurate disclosure followed 100 % of open-ended and normalizing questions, 58 % of closed-ended questions, and 22 % of leading questions. After adjusting for drug type, closed-ended questions were 41 % less likely (p < 0.001), and 'leading' questions 78 % less likely (p = 0.016) than broad and normalizing questions to elicit disclosures. CONCLUSION: Providers in this sample missed almost half of the opportunities to identify and discuss substance use with PLWH. Providers can increase the probability of patient disclosure by using open-ended or normalizing questions that ask about the "last time" that the patient used drugs or alcohol.
BACKGROUND: Substance use is associated with higher rates of antiretroviral non-adherence and poor HIV outcomes. This study examined how HIV care providers assess substance use, and which questions elicit accurate patient disclosures. METHODS: We conducted a conversation analysis of audio-recorded encounters between 56 providers and 162 patients living with HIV (PLWH) reporting active substance use in post-encounter interviews (cocaine or heroin use in the past 30 days, > 4 days intoxicated in past 30 days, or AUDIT score ≥ 8). We assessed the frequency of substance use discussion, characterized the types of questions used by providers, and determined the frequency of accurate patient disclosure by question type. RESULTS: In 55 reports of active substance use, providers already knew about the use (n = 16) or patients disclosed unpromptednn = 39). Among the remaining 155 instances of substance use in which providers had the opportunity to elicit disclosure, 78 reports (50 %) of substance use were not discussed. Of the remaining 77 reports in which the provider asked about substance use, 55 (71 %) patients disclosed and 22 (29 %) did not disclose. Questions were classified as: open-ended (n = 18, "How's the drinking going?"); normalizing (n = 14, "When was the last time you used?"); closed-ended (n = 36, "Have you used any cocaine?"); leading towards non-use (n = 9, "Have you been clean?"). Accurate disclosure followed 100 % of open-ended and normalizing questions, 58 % of closed-ended questions, and 22 % of leading questions. After adjusting for drug type, closed-ended questions were 41 % less likely (p < 0.001), and 'leading' questions 78 % less likely (p = 0.016) than broad and normalizing questions to elicit disclosures. CONCLUSION: Providers in this sample missed almost half of the opportunities to identify and discuss substance use with PLWH. Providers can increase the probability of patient disclosure by using open-ended or normalizing questions that ask about the "last time" that the patient used drugs or alcohol.
Entities:
Keywords:
HIV/AIDS; patient–provider communication; substance use
Authors: Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum Journal: J Gen Intern Med Date: 2002-05 Impact factor: 5.128
Authors: Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore Journal: AIDS Behav Date: 2007-03
Authors: John S Cacciola; Arthur I Alterman; A Thomas McLellan; Yi-Ting Lin; Kevin G Lynch Journal: Drug Alcohol Depend Date: 2006-10-11 Impact factor: 4.492
Authors: P Todd Korthuis; Somnath Saha; Geetanjali Chander; Dennis McCarty; Richard D Moore; Jonathan A Cohn; Victoria L Sharp; Mary Catherine Beach Journal: AIDS Behav Date: 2011-05
Authors: Moira K Ray; Mary Catherine Beach; Christina Nicolaidis; Dongseok Choi; Somnath Saha; P Todd Korthuis Journal: Fam Med Date: 2013-02 Impact factor: 1.756
Authors: Eric J Hawkins; Daniel R Kivlahan; Emily C Williams; Steven M Wright; Thomas Craig; Katharine A Bradley Journal: Subst Abus Date: 2007 Impact factor: 3.716
Authors: Joseph Cofrancesco; Rebecca Scherzer; Phyllis C Tien; Cynthia L Gibert; Heather Southwell; Stephen Sidney; Adrian Dobs; Carl Grunfeld Journal: AIDS Date: 2008-01-30 Impact factor: 4.177
Authors: Catherine R Lesko; Alexander P Keil; Richard D Moore; Geetanjali Chander; Anthony T Fojo; Bryan Lau Journal: Am J Epidemiol Date: 2018-09-01 Impact factor: 4.897
Authors: Catherine R Lesko; Alexander P Keil; Anthony T Fojo; Geetanjali Chander; Bryan Lau; Richard D Moore Journal: Am J Epidemiol Date: 2019-10-01 Impact factor: 4.897